氧化铁 (II,III)，纳米颗粒

Iron oxide (II,III), nanoparticles

I466553-1ml

1ml

30nm 平均粒径(TEM), 链霉亲和素功能化, 1mg/mL in H₂O

禁止冷冻

Description Recent docking studies highlight the potential interaction of iron oxide (II,III) nanoparticles (IONPs) with the SARS-CoV-2 spike protein receptor binding domain. This may target viral entry in host cells and also render virions inactive.IONPs may be used in the nanoparticle preparation for evaluation of their antiviral property against H1N1 influenza A virus.Iron oxide nanoparticles exhibit biocompatibility and non-toxicity and are used as magnetic resonance imaging contrast agents, gene carriers for gene therapy, therapeutic agents for hyperthermia-based cancer treatment, magnetic sensing probes forin vivodiagnostics and for target specific drug delivery.